Nxera Pharma Co., Ltd.
Biotechnology · Healthcare
CFO
3 appearances
Latest appearance 2026-08-07
CFO
Nxera Pharma Co., Ltd.
Equibles does not estimate personal net worth.
Hironoshin Nomura is recorded as CFO at Nxera Pharma Co., Ltd.. Hironoshin Nomura has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Nxera Pharma Co., Ltd. on August 7, 2026. Nxera Pharma Co., Ltd. is classified in the Biotechnology industry within the Healthcare sector.
“Now, it is time to start Nextera Pharma webinar for first half FY2026 financial results. Thank you very much for joining, despite your very busy schedule. My name is Nomura, CEO of the company serving as the MC.”
“Yeah, actually, Chris covered basically all, but it's very encouraging, and we are very happy about the Ono's progression, because it shows a clear efficacy in our perspective, and especially in some type of biomarkers, subgroups.”
“From now, we would like to start Nexera Pharma's FY2025 for your financial results briefing. Thank you very much for joining. Despite your very busy schedule, I will be serving as the MC today, CFO Nomura.”
Nxera Pharma Co., Ltd.
CFO
Transcript header (unverified)
Nxera Pharma Co., Ltd.
Biotechnology · Healthcare
CFO
H1 FY2026 Financial Results
Nxera Pharma Co., Ltd.
Jefferies Global Healthcare Conference
Nxera Pharma Co., Ltd.
FY2025 Financial Results
Nxera Pharma Co., Ltd.